Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...
In the INS class, fluticasone propionate (Flonase ... The second addition was the US launch of ciclesonide (Omnaris) by Sepracor in January 2008. Sepracor acquired the US rights to Omnaris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback